Business Description
![iRhythm Technologies Inc iRhythm Technologies Inc logo](https://static.gurufocus.com/logos/0C0000B5QC.png?14)
iRhythm Technologies Inc
NAICS : 339112
SIC : 3841
ISIN : US4500561067
Description
iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.77 | |||||
Equity-to-Asset | 0.1 | |||||
Debt-to-Equity | 8.16 | |||||
Debt-to-EBITDA | -7.36 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | 2.28 | |||||
Beneish M-Score | -2.37 | |||||
WACC vs ROIC |
Growth Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 19.1 | |||||
3-Year EBITDA Growth Rate | -44.6 | |||||
3-Year EPS without NRI Growth Rate | -33.4 | |||||
3-Year FCF Growth Rate | -44.4 | |||||
3-Year Book Growth Rate | -16.8 | |||||
Future 3-5Y Total Revenue Growth Rate | 17.99 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 82.96 | |||||
9-Day RSI | 74.78 | |||||
14-Day RSI | 67.27 | |||||
6-1 Month Momentum % | -19.36 | |||||
12-1 Month Momentum % | -12.99 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.1 | |||||
Quick Ratio | 6.95 | |||||
Cash Ratio | 5.88 | |||||
Days Inventory | 31.59 | |||||
Days Sales Outstanding | 42.95 | |||||
Days Payable | 16.42 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.2 | |||||
Shareholder Yield % | -3.77 |
Profitability Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 66.96 | |||||
Operating Margin % | -21.97 | |||||
Net Margin % | -25.33 | |||||
FCF Margin % | -22.05 | |||||
ROE % | -67.28 | |||||
ROA % | -24.67 | |||||
ROIC % | -51.12 | |||||
ROC (Joel Greenblatt) % | -75.99 | |||||
ROCE % | -28.69 |
GF Value Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.44 | |||||
PB Ratio | 37.07 | |||||
Price-to-Tangible-Book | 37.36 | |||||
EV-to-EBIT | -28.41 | |||||
EV-to-EBITDA | -35.1 | |||||
EV-to-Revenue | 6.85 | |||||
EV-to-Forward-Revenue | 6.03 | |||||
EV-to-FCF | -31.06 | |||||
Earnings Yield (Greenblatt) % | -3.52 | |||||
FCF Yield % | -3.38 |